Life Sciences

The great telehealth experiment

06/2022
a doctor using tablet

Integrating new technology systems into large institutions is notoriously difficult even when it is carefully planned. So how has the rapid roll-out of telehealth during the pandemic altered the risk landscape?

COVID-19 has fast-tracked and consolidated the adoption of healthcare information technology, or telehealth, into mainstream healthcare as face-to-face appointments became risky for patients and healthcare workers alike when the virus took hold.

In the blink of an eye, doctors’ appointments were delivered by video, electronic prescriptions became widespread and triage went online. Aside from the convenience it offers many patients, telehealth has also been creating efficiencies within healthcare systems as specialist services get accessed via video links. In addition, the technology has also been central to strategies for fighting the virus through contact tracing apps, for instance.

The cross-section of applications for telehealth found during the pandemic hints at the sector’s breadth and potential.

However, its rapid rise to prominence means that systems have not been integrated as carefully as they would have in normal times. Where largescale IT projects ordinarily take years to implement, the adoption of telehealth happened in a matter of weeks and months. The underlying risks associated with accelerated digital transformation on a massive scale in the sector range from privacy and data breaches to errors and omissions – all of which need to be addressed.

Read “The Great Telehealth Experiment” report to learn how the sudden rise in telehealth services during the pandemic has given patients and healthcare professionals a glimpse into the benefits of digital transformation, along with the risks that must be managed.

Key takeaways

  • The pandemic has fast-tracked telehealth into the mainstream.
  • Data compatibility issues between systems can undermine good projects.
  • Doctors need training to interpret all of the data they are now receiving.
  • Technology companies need to be careful when documenting project requirements under time pressure.
  • In the future, patients will have more health data at their fingertips and AI will play a big role in diagnosis.

Download

The great telehealth experiment

Read more reports in the ‘Life Science in the era of pandemics’ series:

Insights and Expertise

We keep you informed — and your business protected — with these helpful articles.
Close-up of a microscope in a life sciences laboratory

3 key risks facing the life sciences industry

Cyber threats, U.S. product liability and fragile supply chains are the three biggest risks facing life sciences companies today — and how to manage them.
medical devices

Making medical devices during a pandemic

How has the coronavirus pandemic affected the risk profile of medical device manufacturing?
medical equipment

3 big questions with life science expert Travis McIntosh

What do the new COVID-19 vaccines mean to insurers and the Life Science industry at large? How has COVID-19 affected Life Science companies?
abstract virus

Emerging risks in COVID-19 clinical trials

As the scientific community races to respond to COVID-19, best practice is slipping in clinical trials. What trade-offs are being made and who is liable?
bright dna spiral

Fighting COVID-19 with genomics

Advances in genomics are turbocharging the global response to the COVID-19 pandemic and continuing to redefine how we understand healthcare
lessons from the supply chain

Lessons from the supply chain

The vulnerabilities of the life science supply chain are at the forefront of everyone’s minds. But, behind the headlines, how is the pandemic affecting attitudes to risk?

Have a question or need more information?

Contact us to find out how we can help you get covered against potential risks.